GlycoFlux™ Human GCG Overexpression HEK293 Cell Line (CAT#: GLJF-0925-JF399)

Description	GlycoFlux™ human GCG overexpression HEK293 cell line is a stable glycoengineered line that constitutively overexpresses preproglucagon, yielding glucagon and gut peptides after prohormone processing. This system enables secretion-pathway and peptidomics workflows to test how Golgi maturation and granule biogenesis influence peptide processing, packaging, and receptor-ligand pharmacology in a glyco-aware context.
Product Type	Overexpression Cell Lines
Species	Human
Cell Morphology	Epithelial-like, adherent
Passage Ratio	1:2~1:4
Cell Line	HEK293
Lineage	Embryonic kidney

Cell Viability	>90%
Sterility Test	The sterility test indicated an absence of microbial growth.
Identity Test	STR identification
Mycoplasma Test	Negative
Virus Test	Negative for HIV, HBV and HCV.
Genetic Stability Testing	We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation	qPCR, Sanger Sequencing
Culture Medium	FBS & Penicillin/Streptomycin & Proline & DMEM
Application	Mechanistic studies; Exploration of glycosylation and signaling pathways in cancer, metabolic, and immune-related diseases; Drug target validation and other functional assays.
Size	1 M cells/vial*2
Product Format	Frozen
Shipping	Dry ice
Availability Status	Made to order
Handling Notes	Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer	This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

Target	GCG
Full Name	Glucagon
Alternative Name	GLP1; GLP2; GRPP; GLP-1
Location	2q24.2
Gene ID	2641
Summary	This gene encodes a preproprotein that is cleaved into four peptides. One peptide, glucagon, counters insulin by stimulating glycogenolysis and gluconeogenesis. Glucagon also regulates cell proliferation through its receptor signaling. Two other peptides are involved in nutrient absorption, while the fourth is similar to glicentin, an enteroglucagon.